Pros | - | 5Y returns in the top 25% of the category. 3Y returns in the top 25% of the category. Among most bought funds within the category. | ||
Cons | - | - |
INDMoney rank | - | 1/8 | ||
Category | Equity,Sector - Healthcare | Equity,Sector - Healthcare | ||
Fund Age | 6 Months | 7 Years 6 Months | ||
Fund AUM | ₹611 Cr | ₹6460 Cr | ||
Min Investment | SIP ₹500 Lumpsum ₹1000 | SIP ₹100 Lumpsum ₹5000 | ||
Expense Ratio | 0.43% | 1.03% | ||
Exit Load | 1% | 1% | ||
Benchmark Index | BSE Healthcare TR INR | BSE Healthcare TR INR |
No of Holdings | 30 | 41 | ||
Top 5 Holdings | Sun Pharmaceuticals Industries Ltd (8.99%) Mankind Pharma Ltd (7%) Cipla Ltd (6.51%) Max Healthcare Institute Ltd Ordinary Shares (6.28%) Apollo Hospitals Enterprise Ltd (6%) | Sun Pharmaceuticals Industries Ltd (12.83%) Dr Reddy's Laboratories Ltd (9.81%) Cipla Ltd (8%) Divi's Laboratories Ltd (7.48%) Aurobindo Pharma Ltd (6.04%) | ||
No of Sectors | 2 | 3 | ||
Top 3 Sectors | Health (96.96%) Financial Services (3.04%) | Health (97.66%) Basic Materials (1.19%) Financial Services (1.15%) | ||
Equity % | 100.3% | 97.7% | ||
Debt % | - | - | ||
P/E | 40.14 | 31.48 | ||
P/B | 5.92 | 4.31 | ||
Credit Quality | - | - | ||
Modified Duration | - | - | ||
YTM | - | - |
1-Month Return | -0.99% | 0.09% | ||
3-Month Return | -2.35% | -0.41% | ||
6-Month Return | - | 4.45% | ||
1-Year Return | - | 4.32% | ||
3-Year Return | - | 28.97% | ||
5-Year Return | - | 19.11% |
Sharpe | - | 1.25 | ||
Alpha | - | 3.97 | ||
Beta | - | 0.95 | ||
Standard Deviation | - | 15.7 | ||
Information Ratio | - | 1.26 |
Description | Baroda BNP Paribas Health and Wellness Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund is an equity fund.The fund could potentially beat inflation in the long-run. | ||
Managers | Sanjay Chawla | Dharmesh Kakkad,Sharmila D’mello |